Stratasys' Objet Eden260V 3D Printer Wins Dental Advisor's Top Innovative Equipment Award | Be Korea-savvy

Stratasys’ Objet Eden260V 3D Printer Wins Dental Advisor’s Top Innovative Equipment Award


Objet Eden260V 3D Printer from Stratasys (image: Stratasys/PRNewswire)

Objet Eden260V 3D Printer from Stratasys (image: Stratasys/PRNewswire)

MINNEAPOLIS and REHOVOT, Israel, January 30, 2014 (Korea Bizwire) – Stratasys, Ltd. (NASDAQ:   SSYS), a manufacturer of 3D printers and materials for personal use, prototyping and production,  today announced that the Objet Eden260V 3D Printer has won the 2014 Product Award for Top Innovative Equipment from The Dental Advisor magazine. The Objet Eden260V 3D Printer was the only rapid prototyping platform honored in the magazine’s annual “Product Award” list for the second year in a row. The magazine sited the system’s outstanding surface detail, easy management and maintenance, high resolution in all axes, and high speed in high quality 3D printing modes as reasons for its selection.

“We are honored to be recognized by The Dental Advisor for the second year  in a row. The high degree of interest reflects 3D printing’s growing importance in digitizing dentistry and the significant value that the Objet Eden260V 3D Printer has in redefining manufacturing in the dental lab industry,” said Avi Cohen, Director of Global Dental, Stratasys. “Through the use of proven Objet 3D Printers for additive manufacturing and dental models with our advanced, medically approved materials, our customers are able to provide highly accurate and excellent-quality dental models and parts efficiently and cost-effectively. Moreover, dental labs are increasingly using the Objet-line of 3D Printers to offer a greater variety of dental solutions to their dentist clients, including in-house fabrication of fine detail models with outstanding surface finish.”

We believe that 3D printing is one of the key factors driving the new digital era in dentistry. By combining oral scanning, CAD/CAM design and 3D printing, dental labs can accurately and rapidly produce dental stone models, and a range of orthodontic appliances for dental offices. The Objet Eden260V 3D Printer can provide dental labs with an ideal platform for a digitized workflow, enabling more efficient and cost effective production without the need for costly expansion of staff and facilities.

The Dental Advisor product awards are chosen through lengthy discussions, voting, and agreement from the publication’s prestigious Editorial Board, which consists of respected dental professionals with experience in all areas of clinical dentistry, as well as dental research.

This most recent recognition joins a growing list of awards earned by the Stratasys Objet-line of Dental 3D Printers, including the Dental Advisor 2013 Top Innovative Equipment Award, and the Dental Labs Products 2011 Readers Choice Award.

For more on Stratasys Dental Solutions for Dental Labs interested in digitizing their workflow, contact Dental@stratasys.com also see Stratasys Dental videos

Stratasys Ltd. (Nasdaq:   SSYS), headquartered in Minneapolis, Minn. and Rehovot, Israel, manufactures 3D printers and materials for prototyping and production. The company’s patented FDM® and PolyJet[TM]3D Printing technologies produce prototypes and manufactured goods directly from 3D CAD files or other 3D content. Systems include 3D printers for idea development, prototyping and direct digital manufacturing. Stratasys subsidiaries include MakerBot and Solidscape, and the company operates the RedEye digital-manufacturing service. Stratasys has more than 1700 employees, holds over 500 granted or pending additive manufacturing patents globally, and has received more than 20 awards for its technology and leadership. Online at: http://www.stratasys.com or http://blog.stratasys.com

Cautionary Statement Regarding Forward-Looking Statements

Certain information included or incorporated by reference in this press may be deemed to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are often characterized by the use of forward-looking terminology such as “may,” “will,” “expect,” “anticipate,” “estimate,” “continue,” “believe,” “should,” “intend,” “project” or other similar words, but are not the only way these statements are identified.  These forward-looking statements may include, but are not limited to, statements relating to the company’s objectives, plans and strategies, statements regarding the company’s products and their expected performance, statements that contain projections of results of operations or of financial condition (including, with respect to the MakerBot merger) and all statements (other than statements of historical facts) that address activities, events or developments that the company intends, expects, projects, believes or anticipates will or may occur in the future.  Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. The company has based these forward-looking statements on assumptions and assessments made by its management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate.  Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements include, among other things: the company’s ability to efficiently and successfully integrate the operations of Stratasys, Inc. and Objet Ltd. after their merger as well as the ability to successfully integrate MakerBot into Stratasys; the overall global economic environment; the impact of competition and new technologies; general market, political and economic conditions in the countries in which the company operates; projected capital expenditures and liquidity; changes in the company’s strategy; government regulations and approvals; changes in customers’ budgeting priorities; litigation and regulatory proceedings; and those factors referred to under “Risk Factors”, “Information on the Company”, “Operating and Financial Review and Prospects”, and  generally in the company’s annual report on Form 20-F for the year ended December 31, 2012 filed with the U.S. Securities and Exchange Commission and in other reports that the Company has filed with the SEC. Readers are urged to carefully review and consider the various disclosures made in the company’s SEC reports, which are designed to advise interested parties of the risks and factors that may affect its business, financial condition, results of operations and prospects. Any forward-looking statements in this press release are made as of the date hereof, and the company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

PolyJet, Eden are trademarks, and Stratasys and Objet are registered trademarks of Stratasys Ltd ans or its subsidiaries or affiliates.

Attention Editors, if you publish reader-contact information, please use:

  • USA: 1-877-489-9449
  • Europe/Middle East/Africa: +49-7229-7772-0
  • Asia Pacific: +852 39448888

 

SOURCE:  Stratasys Ltd. (via PR Newswire)

 

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>